Table 5 Comparisons of baseline demographics and echocardiographic parameters between appropriate and inappropriate left ventricular mass
|  | Appropriate LVM (n = 56) | Inappropriate LVM (n = 83) | P value |
|---|---|---|---|
Age (years) | 61.73 ± 11.55 | 65.36 ± 9.16 | 0.052 |
Gender (M/F) | 40/16 | 44/39 | 0.03 |
Skin AF (A.U.) | 2.03 ± 0.42 | 2.47 ± 0.46 | <0.01 |
BMI (kg/m2) | 26.57 ± 3.61 | 26.09 ± 3.55 | 0.44 |
SBP (mmHg) | 143.59 ± 13.66 | 138.82 ± 17.00 | 0.08 |
DBP (mmHg) | 81.60 ± 12.72 | 75.84 ± 10.98 | <0.01 |
PP (mmHg) | 62.62 ± 14.42 | 63.10 ± 13.22 | 0.84 |
Hypertension n (%) | 49 (87.50) | 67 (80.72) | 0.29 |
DM, n (%) | Â | Â | 0.20 |
 None, n (%) | 36 (64.29) | 54 (65.06) |  |
 OHA, n (%) | 19 (33.93) | 22 (26.51) |  |
 RI, n (%) | 1 (1.78) | 7 (8.43) |  |
Hyperlipidemia, n (%) | 41 (73.21) | 68 (81.92) | 0.22 |
Stroke, n (%) | 2 (3.57) | 8 (9.64) | 0.18 |
IHD, n (%) | 7 (12.50) | 23 (27.71) | 0.03 |
PAOD, n (%) | 0 (0) | 2 (2.41) | 0.24 |
LVMI (g/m2.7) | 44.56 ± 9.28 | 60.91 ± 16.83 | <0.01 |
eGFR (mL/min/1.73 m2) | 67.17 ± 15.76 | 62.53 ± 22.92 | 0.16 |
Antiplatelets, n (%) | 35 (62.50) | 56 (67.47) | 0.55 |
β-Blockers, n (%) | 21 (37.50) | 38 (45.78) | 0.33 |
CCBs, n (%) | 28 (50.00) | 34 (40.96) | 0.29 |
ACEIs/ARBs, n (%) | 42 (75.00) | 50 (60.24) | 0.07 |
Statins, n (%) | 30 (53.57) | 51 (61.45) | 0.36 |
Smoking | Â | Â | 0.21 |
 Never, n (%) | 43 (76.79) | 52 (62.65) |  |
 Ever, n (%) | 9 (16.07) | 20 (24.10) |  |
 Active, n (%) | 4 (7.14) | 11 (13.25) |  |
LVEF (%) | 69.27 ± 8.16 | 66.04 ± 7.26 | 0.02 |
LA diameter (mm) | 35.78 ± 4.20 | 37.98 ± 4.85 | <0.01 |
E (cm/s) | 73.31 ± 14.73 | 75.52 ± 18.99 | 0.47 |
A (cm/s) | 88.13 ± 17.26 | 92.61 ± 24.02 | 0.23 |
E/A ratio | 0.86 ± 0.26 | 0.85 ± 0.25 | 0.80 |
E′ (SW) (cm/s) | 7.44 ± 2.11 | 6.49 ± 2.02 | <0.01 |
A′ (SW) (cm/s) | 10.35 ± 1.93 | 9.40 ± 2.15 | <0.01 |
E/E′ ratio | 10.65 ± 3.76 | 12.56 ± 4.47 | <0.01 |
DT (ms) | 220.09 ± 38.58 | 219.91 ± 53.14 | 0.98 |